About Aptahem
Business Strategy
Business Model
History
Team
Portfolio
RNA-therapeutics
Apta-1
Apta-2
Apta-3
Intellectual Property and Patent
Our Research
Scientific Collaborations
Örebro Consortium
Seattle Children’s Research Institute (SCRI)
University Health Network (UHN)
Publications
Production
Mechanism of Action
About Sepsis
Investor
Rights Issue Autumn 2024
Market Potential
Company Information
Share information
General Meetings
Largest Owners
Financial Reports
Annual Reports
Interim Reports
Financial Calendar
Events
Share issues
Analyzes
Nomination Committee
Media
News
Newsletter
Presentations
Sepsis Seminar 2021
Contact
About Aptahem
Business Strategy
Business Model
History
Team
Portfolio
RNA-therapeutics
Apta-1
Apta-2
Apta-3
Intellectual Property and Patent
Our Research
Scientific Collaborations
Publications
Production
Mechanism of Action
About Sepsis
Investor
Rights Issue Autumn 2024
Market Potential
Company Information
Share information
General Meetings
Largest Owners
Financial Reports
Financial Calendar
Events
Share issues
Analyzes
Nomination Committee
Media
News
Newsletter
Presentations
Sepsis Seminar 2021
Contact
Annual Reports
Annual Reports
Interim Reports
The documents are only available in Swedish
2023
Annual Report 2023
2022
Annual Report 2022
2021
Annual Report 2021
2020
Annual Report 2020
2019
Annual Report 2019
2018
Annual Report 2018
2017
Annual Report 2017
2016
Annual Report 2016
2015
Annual Report 2015
2014
Annual Report 2014
